Journal article · 2024

Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma

Qing Zhu, Silüe Zeng, Junying Yang, Jiaming Zhuo, Peifeng Wang, Sai Wen, Chihua Fang

Nanoscale, 16(39), 18584–18596 · Published 10 October 2024 · DOI 10.1039/d4nr01587h

View at the publisherCite this paper

In brief

“Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma” is a 2024 journal article by Qing Zhu and 6 co-authors, published in Nanoscale. OpenAlex counts 7 citations as of 21 November 2026, which puts it in the top 5% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
7
Most cited in
2026 (4)
Field-weighted impact
0.52
References
39
Authors
7

Abstract

Pancreatic ductal adenocarcinoma (PDAC) poses a formidable challenge due to its aggressive nature and poor prognosis. Gemcitabine (Gem), a primary therapeutic option, functions by inhibiting DNA synthesis and promoting apoptosis, thereby impeding the progression of PDAC. However, Gem is hindered by suboptimal pharmacokinetics and efficacy. In response to these challenges, we have developed a nanoparticle… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhu, Q., Zeng, S., Yang, J., Zhuo, J., Wang, P., Wen, S., & Fang, C. (2024). Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma. Nanoscale, 16(39), 18584–18596. https://doi.org/10.1039/d4nr01587h

MLA 9

Zhu, Qing, et al. “Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma.” Nanoscale, vol. 16, no. 39, 2024, pp. 18584–18596. https://doi.org/10.1039/d4nr01587h.

Chicago

Zhu, Qing, Silüe Zeng, Junying Yang, Jiaming Zhuo, Peifeng Wang, Sai Wen, and Chihua Fang. 2024. “Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma.” Nanoscale 16 (39): 18584–18596. https://doi.org/10.1039/d4nr01587h.

Harvard

Zhu, Q. et al. (2024) ‘Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma’, Nanoscale, 16(39), pp. 18584–18596. doi:10.1039/d4nr01587h.

IEEE

Q. Zhu et al., “Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma,” Nanoscale, vol. 16, no. 39, pp. 18584–18596, 2024, doi: 10.1039/d4nr01587h.

BibTeX

@article{zhu2024plectin,
  title     = {{Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma}},
  author    = {Zhu, Qing and Zeng, Silüe and Yang, Junying and Zhuo, Jiaming and Wang, Peifeng and Wen, Sai and Fang, Chihua},
  journal   = {Nanoscale},
  year      = {2024},
  volume    = {16},
  number    = {39},
  pages     = {18584--18596},
  doi       = {10.1039/d4nr01587h},
  url       = {https://doi.org/10.1039/d4nr01587h}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic ductal adenocarcinoma
  • gemcitabine
  • targeted drug delivery
  • pH-responsive nanoparticles
  • indocyanine green
  • photothermal therapy
  • combination chemotherapy
  • tumor microenvironment

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Zhu, Q., Zeng, S., Yang, J., Zhuo, J., Wang, P., Wen, S., & Fang, C. (2024). Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma. Nanoscale, 16(39), 18584–18596. https://doi.org/10.1039/d4nr01587h

How many times has this paper been cited?

7 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Qing Zhu, Silüe Zeng, Junying Yang, Jiaming Zhuo, Peifeng Wang, Sai Wen, Chihua Fang.

What is the DOI of this paper?

10.1039/d4nr01587h, permanently at https://doi.org/10.1039/d4nr01587h. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.